[1] STINO A, SMITH A. Peripheral neuropathy in prediabetes and the metabolic syndrome[J].J Diabetes Investig,2017,8(5):646-655. [2] 伍一鸣.2型糖尿病周围神经病变患者血清中NSE、Hcy、CRP的表达及其临床意义[J].医学临床研究,2019,36(6):1157-1159. [3] LIU X, XU Y, AN M, et al. The risk factors for diabetic peripheral neuropathy: A meta-analysis[J].PLoS One,2019,14(2):e212574. [4] FENG Y, CHEN L, LUO Q, et al. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation[J].Drug Des Devel Ther,2018,12:171-177. [5] 周雯,方颖,储全根, 等.黄芪桂枝五物汤对糖尿病周围神经病变大鼠血清IL-1β、TNF-α、NGF和坐骨神经NGFmRNA的影响[J].安徽中医药大学学报,2020,39(3):67-71. [6] ROJEWSKA E, ZYCHOWSKA M, PIOTROWSKA A, et al. Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine[J].Front Immunol,2018,9:494. [7] 陈明月,蔡慧敏,陈江云等.密歇根糖尿病神经病变评分和多伦多临床评分系统在糖尿病周围神经病变中的诊断价值研究[J].中国全科医学,2017,20(4):427-431. [8] AMERICAN DIABETES ASSOCIATION. Diagnosis and classification of diabetes mellitus[J].Diabetes Care,2013,36(Suppl):S67-S74. [9] 袁媛.血清铁蛋白与氧化应激在糖尿病周围神经病变患者中的变化及临床意义[J].国际检验医学杂志,2018,39(12):1508-1510. [10] 张苏,冷锦红.Nrf2-NF-κB轴在痛性糖尿病性周围神经病变中的作用[J].实用医院临床杂志,2019,16(3):253-255. [11] 杜宏,王扬天,赵明, 等.糖尿病大鼠心肌NF-κB、iNOS、COX-2表达的研究[J].中国病理生理杂志,2008,24(1):80-83. [12] 王宁丁,刘晓秋,伍军军, 等.补中益气丸对糖尿病大鼠胃黏膜诱导型一氧化氮合酶及环氧化酶2表达的影响[J].吉林中医药,2015,35(3):279-282. [13] 王英.JAK-STAT信号传导通路与痛性糖尿病周围神经病变关系的研究进展[J].疑难病杂志,2018,17(10):1176-1178. [14] 冷玉琳,杨婵,唐诗韵, 等.连梅汤治疗糖尿病周围神经病变机理探讨[J].中国中医基础医学杂志,2019,25(3):369-370.
2021, Vol. 38 
